Statin Use and Reduced Risk of Pneumonia in Patients with MelioidosisANNALS OF THE AMERICAN THORACIC SOCIETYIF5.42024-02-010OAAI
Prospective Analysis of Antibody Diagnostic Tests and TTS1 Real-Time PCR for Diagnosis of Melioidosis in Areas Where It Is EndemicJOURNAL OF CLINICAL MICROBIOLOGYIF5.42023-03-238OAAI
Characteristics and one year outcomes of melioidosis patients in Northeastern Thailand: a prospective, multicenter cohort studyLANCET REGIONAL HEALTH - SOUTHEAST ASIAIF6.22023-02-0135OAAI
Melioidosis Patient Survival Correlates With Strong IFN-γ Secreting T Cell Responses Against Hcp1 and TssMFRONTIERS IN IMMUNOLOGYIF5.92021-07-3013OAAI
Antibiotic Susceptibility of Clinical Burkholderia pseudomallei Isolates in Northeast Thailand from 2015 to 2018 and the Genomic Characterization of β-Lactam-Resistant IsolatesANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52021-04-199OAAI
Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis血液转录组学表征关键生物学途径并鉴定预测类鼻疽死亡率的生物标志物EMERGING MICROBES & INFECTIONSIF7.52021-01-179OAAI
Longitudinal profiling of plasma cytokines in melioidosis and their association with mortality: a prospective cohort study类鼻疽中血浆细胞因子的纵向分布及其与死亡率的关系: 一项前瞻性队列研究CLINICAL MICROBIOLOGY AND INFECTIONIF8.52020-06-0119OAAI
A 2-Biomarker Model Augments Clinical Prediction of Mortality in MelioidosisCLINICAL INFECTIOUS DISEASESIF7.32020-02-0810OAAI